BPA Call 36C25524A0009-36C25526N0036
- Not listed
- The Veterans Integrated Service Network 2 (VISN 2) awarded a Blanket Purchase Agreement (BPA) call valued at $19,603.80 to Optum Pharmacy 801, Inc. on November 20, 2025, for the supply of chemotherapy compound for use within the Veterans Health Administration. This firm fixed-price contract will be performed in Phoenix, Arizona, and is scheduled for completion by November 16, 2026. The award was made without a set-aside designation through a competitive procurement process. Optum Pharmacy 801,...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 16 (VISN 16), awarded a delivery order valued at $1.35M to Optum Pharmacy 801, Inc. for hazardous pharmaceutical compounding services. The contract, which commenced on October 1, 2024, and extends through September 30, 2029, was awarded on a firm fixed-price basis without set-aside designation through full and open competition. The work will be performed in Biloxi, Mississippi, and involves the preparation of...
- Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, was awarded a delivery order valued at approximately $1.1 million by Veterans Integrated Service Network (VISN) 17 for pharmacy compounding services supporting the Dallas and Amarillo VA Medical Centers. This contract, effective June 1, 2025, with an ultimate completion date of October 31, 2025, was awarded on a firm fixed-price basis without any set-aside designation. The award represents an administrative modification...
- This is a definitive, firm-fixed-price contract awarded by the Department of Veterans Affairs (VA) to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated. The contract, valued at $4,519,085.96, is for sterile hazardous compounding services to be provided to the VA's Veterans Integrated Service Network (VISN) 16, which covers facilities in Arkansas. The contract has a period of performance through December 25, 2024 and was not set aside for any particular business type. Optum...
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated. The contract, valued at $5,773,549.83, is for the provision of pharmacy compounding services, including sterile hazardous drug compounding, emergency compounding, and chemotherapy IV medications. The contract has a period of performance through September 30, 2024. Optum Pharmacy 601 has received multiple awards from various Veterans...
- Optum Pharmacy 801, Inc., a UnitedHealth Group subsidiary, was awarded a $467,562.30 firm fixed-price delivery order by Veterans Integrated Service Network (VISN) 2 on April 1, 2025, for short-term chemotherapy compounding services. The contract, which requires completion by September 30, 2025, will be performed in Phoenix, Arizona. This delivery order was awarded through full and open competition with no set-aside designation and represents a task order issued under VISN 2's existing...
- Optum Infusion Services 308, LLC, a subsidiary of UnitedHealth Group Incorporated, received a $750,000 Blanket Purchase Agreement (BPA) call for contingency pharmacy compounding products and services from the Veterans Integrated Service Network 16 (VISN 16). The contract was awarded on December 26, 2025, under a firm fixed-price structure with no set-aside designation and will be performed in Chandler, Arizona, with an ultimate completion date of December 25, 2030. As a BPA call, this award...
- This is a federal contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian agency, to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The contract is for a Blanket Purchase Agreement (BPA) call to provide chemotherapy compound JJP at a firm-fixed price of $20,583.99. The award has an ultimate completion date of November 16, 2026. This contract is not set aside and was awarded through full and open competition. Optum Pharmacy 801, Inc. is a...
- Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, was awarded a $400,000 firm fixed-price delivery order by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 20 (VISN 20) for pharmacy compounding services. The delivery order, which commenced on December 1, 2025, and is scheduled for completion by November 30, 2026, will be performed at the contractor's facility in Chandler, Arizona. This contract was awarded through full and open competition...
- This federal contract award, valued at $20,000.00, is for Pharmacy Compound Drugs Option Year 4 Order to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated. The contract was awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 2 (VISN 2), to provide pharmacy compounding services, including sterile hazardous drug compounding, emergency compounding, and chemotherapy IV medications. The contract has a firm fixed-price pricing...
- 36C25524A0009Blanket Purchase Agreement
- 36C25524A0009-36C25526N0036BPA Call
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 15 (VISN 15), awarded a $150,000 Blanket Purchase Agreement (BPA) call to Optum Pharmacy 801, Inc. for pharmacy compounding services with a three-month extension period concluding on February 28, 2026. This firm fixed-price contract, awarded on December 1, 2025, represents a task order issued under an existing $8 million BPA for hazardous pharmacy compounding services. The work will be performed in Wichita, Kansas, and no set-aside designation was utilized for this award. Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, specializes in advanced pharmaceutical compounding services for the VA healthcare system, including the preparation of chemotherapy agents, hazardous sterile preparations, and patient-specific intravenous medications as a 503A certified pharmacy. This contract supports VISN 15's critical need for specialized pharmaceutical compounding capabilities to serve veterans' oncology and infusion treatment programs. Optum Pharmacy 801, Inc. has consistently demonstrated its capability to deliver complex pharmaceutical compounding services across multiple VA regions through previous full and open competition contract awards. The underlying BPA vehicle provides the VA with flexible procurement authority to issue task orders for pharmaceutical compounding needs, enabling efficient supply chain management for customized chemotherapy medications and other sterile pharmaceutical preparations essential to veteran healthcare delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $150.0k | 10/14/25 |